Growing interest in extracellular vesicles (EVs, including exosomes and microvesicles) as therapeutic entities, particularly in stem cell-related approaches, has underlined the need for standardization and coordination of development efforts. Members of the International Society for Extracellular Vesicles and the Society ...
Read More »Grail plans to raise $1 billion for liquid biopsy clinical trials
Illumina, Inc. (NASDAQ: ILMN), today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors. GRAIL intends to raise additional capital in the Series B financing ...
Read More »Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Dendritic cell-derived exosomes (Dex) are small extracellular vesicles secreted by viable dendritic cells. In the two phase-I trials conducted using the first generation of Dex (IFN-γ-free) in end-stage cancer, a team led by researchers at Paris-Sud University, reported that Dex ...
Read More »Exosome Sciences To Participate In Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CTE)
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc., announced recently that it has agreed to participate in a clinical research study to establish methods for detecting and diagnosing chronic traumatic encephalopathy (CTE) during life as well as ...
Read More »